Weight-Loss Drug Boom Creates New Headache for Apparel Retailers
U.S. apparel companies face rising product returns as consumers on GLP-1 weight-loss medications experience rapid changes in body size, disrupting clothing fit.
The growing use of GLP-1 weight-loss medications is creating an unexpected problem for U.S. apparel retailers: a surge in product returns. According to recent reports, consumers taking these drugs are experiencing significant and rapid changes in body size, which leads to ill-fitting clothing and subsequent returns.
This trend adds a new operational headache for retailers already dealing with high return rates and logistics costs. The impact is particularly pronounced for online apparel sales, where sizing predictability is lower. Retailers may need to adjust fit policies or sizing standards to accommodate this shift in consumer body composition.
Source: First Squawk